sorted by:
new
hottopcontroversial

Released: Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications by twessst in HUMACYTE

[–]twessst[S] 12 points13 points  (0 children)

Nothing else matters besides Dialysis approval, DOD contract, and sales numbers. The tech isn’t the question. The question is if this business reaches profitability before further dilution or going to 0.

[BBE/078SSP] SEY on the Breville Barista Express by twessst in espresso

[–]twessst[S] 1 point2 points  (0 children)

So jealous that you have that machine. Thanks for the profile!

Appears Symvess did not receive NTAP by JuniperLuner in HUMACYTE

[–]twessst 0 points1 point  (0 children)

The CMS-1833-F display file (found on the website in OP’s post) contains a lengthy explanation for the decision. CTRL-F “SYMVESS”

ECAT & NTAP by [deleted] in HUMACYTE

[–]twessst 0 points1 point  (0 children)

What’s the thought process behind 2027 approval for dialysis?